TFFCX
Price
$66.96
Change
-$0.20 (-0.30%)
Updated
Dec 17 closing price
VTSMX
Price
$145.82
Change
-$0.72 (-0.49%)
Updated
Dec 17 closing price
Ad is loading...

TFFCX vs VTSMX

Header iconTFFCX vs VTSMX Comparison
Open Charts TFFCX vs VTSMXBanner chart's image
Touchstone Focused C
Price$66.96
Change-$0.20 (-0.30%)
VolumeN/A
CapitalizationN/A
Vanguard Total Stock Mkt Idx I
Price$145.82
Change-$0.72 (-0.49%)
VolumeN/A
CapitalizationN/A
TFFCX vs VTSMX Comparison Chart
Loading...
View a ticker or compare two or three
VS
TFFCX vs. VTSMX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TFFCX is a StrongBuy and VTSMX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VTSMX has more cash in the bank: 1.84T vs. TFFCX (1.35B). VTSMX pays higher dividends than TFFCX: VTSMX (1.26) vs TFFCX (0.00). TFFCX was incepted earlier than VTSMX: TFFCX (13 years) vs VTSMX (33 years). TFFCX is a more actively managed with annual turnover of: 5.00 vs. VTSMX (2.00). TFFCX has a lower initial minimum investment than VTSMX: TFFCX (2500) vs VTSMX (3000). VTSMX annual gain was more profitable for investors over the last year : 26.90 vs. TFFCX (20.84). VTSMX return over 5 years is better than : 84.16 vs. TFFCX (59.69).
TFFCXVTSMXTFFCX / VTSMX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years33 years-
Gain YTD20.28026.35277%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets1.35B1.84T0%
Annual Yield % from dividends0.001.26-
Returns for 1 year20.8426.9077%
Returns for 3 years18.2227.8865%
Returns for 5 years59.6984.1671%
Returns for 10 years89.75192.0447%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CANG6.911.42
+25.87%
Cango
CYRX8.140.42
+5.44%
CryoPort
CBOE198.082.43
+1.24%
Cboe Global Markets
ALE64.680.01
+0.02%
ALLETE
PAVM0.68-0.04
-5.61%
PAVmed